Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2010

01-09-2010 | Brief Report

Epidemiology of breast cancer in young women

Author: Marina Pollán

Published in: Breast Cancer Research and Treatment | Special Issue 1/2010

Login to get access

Abstract

Breast cancer is mainly a postmenopausal disease, but in younger women breast tumors often exhibit more aggressive features and worse prognosis. Furthermore, high-risk and low-risk tumors present different age distributions suggesting that breast cancer comprises a mixture of two different disease processes. In agreement with this hypothesis, breast cancer presents different epidemiologic traits in pre- and postmenopausal women. Regarding racial distribution, incidence is higher in black women at younger ages in US, while the reverse is true among women older than 50 years. Genetic predisposition is a stronger risk factor in young women. On the contrary, nulliparity and obesity decrease the risk of early-onset breast cancers while are associated with higher incidence in older women. Epidemiologic data related with the hormonal exposure in utero suggest that the effect is stronger in early breast cancers. In most developed countries, breast cancer has shown an upward trend until recent years in postmenopausal women, while incidence rates in younger women have been stable. However, Spain is an exception to this rule: Spanish women younger than 45 years of age have registered a steady increase of breast cancer that may be related with the remarkable lifestyle changes experienced by women born in the second half of the twentieth century.
Literature
1.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al (2007) Cancer incidence in five continents, IX. IARC Scientific Publications No. 160 Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al (2007) Cancer incidence in five continents, IX. IARC Scientific Publications No. 160
2.
go back to reference Kothari AS, Fentiman IS (2002) Breast cancer in young women. Int J Clin Pract 56(3):184–187PubMed Kothari AS, Fentiman IS (2002) Breast cancer in young women. Int J Clin Pract 56(3):184–187PubMed
3.
go back to reference Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17(5):588–590CrossRefPubMed Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17(5):588–590CrossRefPubMed
4.
go back to reference Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6(5):213–218CrossRefPubMed Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6(5):213–218CrossRefPubMed
5.
go back to reference Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74(11):1796–1800PubMed Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74(11):1796–1800PubMed
6.
go back to reference Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26(20):3324–3330CrossRefPubMed Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26(20):3324–3330CrossRefPubMed
7.
go back to reference Xiong Q, Valero V, Kau V, Kau SW, Taylor S, Smith TL et al (2001) Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer 92(10):2523–2528CrossRefPubMed Xiong Q, Valero V, Kau V, Kau SW, Taylor S, Smith TL et al (2001) Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer 92(10):2523–2528CrossRefPubMed
8.
go back to reference Han W, Kang SY (2010) Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 119(1):193–200CrossRefPubMed Han W, Kang SY (2010) Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 119(1):193–200CrossRefPubMed
9.
go back to reference Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J et al (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 30:44–51 Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J et al (2001) Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 30:44–51
10.
go back to reference Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA et al (2007) Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 18(4):439–447CrossRefPubMed Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA et al (2007) Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 18(4):439–447CrossRefPubMed
11.
go back to reference Anderson WF, Matsuno R (2006) Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 98(14):948–951CrossRefPubMed Anderson WF, Matsuno R (2006) Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 98(14):948–951CrossRefPubMed
12.
go back to reference Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674CrossRefPubMed Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674CrossRefPubMed
13.
go back to reference Allemand H, Seradour B, Weill A, Ricordeau P (2008) Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer 95(1):11–15PubMed Allemand H, Seradour B, Weill A, Ricordeau P (2008) Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer 95(1):11–15PubMed
14.
go back to reference Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107(3):427–430CrossRefPubMed Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107(3):427–430CrossRefPubMed
15.
go back to reference Botha JL, Bray F, Sankila R, Parkin DM (2003) Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39(12):1718–1729CrossRefPubMed Botha JL, Bray F, Sankila R, Parkin DM (2003) Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39(12):1718–1729CrossRefPubMed
16.
go back to reference Pollan M, Pastor-Barriuso R, Ardanaz E, Arguelles M, Martos C, Galceran J et al (2009) Recent changes in breast cancer incidence in Spain, 1980–2004. J Natl Cancer Inst 101(22):1584–1591CrossRefPubMed Pollan M, Pastor-Barriuso R, Ardanaz E, Arguelles M, Martos C, Galceran J et al (2009) Recent changes in breast cancer incidence in Spain, 1980–2004. J Natl Cancer Inst 101(22):1584–1591CrossRefPubMed
17.
18.
go back to reference Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA 288(3):321–333CrossRefPubMed Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA 288(3):321–333CrossRefPubMed
19.
go back to reference MacMahon B, Cole P (2008) Is the incidence of breast cancer declining? Epidemiology 19(2):268–269CrossRefPubMed MacMahon B, Cole P (2008) Is the incidence of breast cancer declining? Epidemiology 19(2):268–269CrossRefPubMed
20.
go back to reference Cabanes A, Ascunce N, Vidal E, Ederra M, Barcos A, Erdozain N et al (2009) Decline in age at menarche among Spanish women born from 1925 to 1962. BMC Public Health 9:449CrossRefPubMed Cabanes A, Ascunce N, Vidal E, Ederra M, Barcos A, Erdozain N et al (2009) Decline in age at menarche among Spanish women born from 1925 to 1962. BMC Public Health 9:449CrossRefPubMed
21.
go back to reference Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM (2008) Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 100(24):1804–1814CrossRefPubMed Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM (2008) Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 100(24):1804–1814CrossRefPubMed
22.
go back to reference Mavaddat N, Pharoah PD, Blows F, Driver KE, Provenzano E, Thompson D et al (2010) Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Res 12(1):R10PubMed Mavaddat N, Pharoah PD, Blows F, Driver KE, Provenzano E, Thompson D et al (2010) Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Res 12(1):R10PubMed
23.
go back to reference Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40(1):17–22CrossRefPubMed Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40(1):17–22CrossRefPubMed
24.
go back to reference Petrek JA, Dukoff R, Rogatko A (1991) Prognosis of pregnancy-associated breast cancer. Cancer 67(4):869–872CrossRefPubMed Petrek JA, Dukoff R, Rogatko A (1991) Prognosis of pregnancy-associated breast cancer. Cancer 67(4):869–872CrossRefPubMed
25.
go back to reference Lukanova A, Toniolo P, Zeleniuch-Jacquotte A, Grankvist K, Wulff M, Arslan AA et al (2006) Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(12):2489–2493CrossRefPubMed Lukanova A, Toniolo P, Zeleniuch-Jacquotte A, Grankvist K, Wulff M, Arslan AA et al (2006) Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(12):2489–2493CrossRefPubMed
26.
go back to reference Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY et al (2008) Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 10(1):R8CrossRefPubMed Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY et al (2008) Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 10(1):R8CrossRefPubMed
27.
go back to reference Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13(2):85–92CrossRefPubMed Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13(2):85–92CrossRefPubMed
28.
go back to reference Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis of epidemiological studies. Int J Cancer 122(8):1832–1841CrossRefPubMed Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis of epidemiological studies. Int J Cancer 122(8):1832–1841CrossRefPubMed
29.
go back to reference Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18(1):137–157CrossRefPubMed Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18(1):137–157CrossRefPubMed
30.
go back to reference Maruti SS, Willett WC, Feskanich D, Rosner B, Colditz GA (2008) A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 100(10):728–737CrossRefPubMed Maruti SS, Willett WC, Feskanich D, Rosner B, Colditz GA (2008) A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 100(10):728–737CrossRefPubMed
Metadata
Title
Epidemiology of breast cancer in young women
Author
Marina Pollán
Publication date
01-09-2010
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue Special Issue 1/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-1098-2

Other articles of this Special Issue 1/2010

Breast Cancer Research and Treatment 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine